The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptamer Group Regulatory News (APTA)

Share Price Information for Aptamer Group (APTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.65
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.05 (7.692%)
Open: 0.675
High: 0.675
Low: 0.675
Prev. Close: 0.675
APTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Apr 2024 15:45

RNS Number : 0952M
Aptamer Group PLC
25 April 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

gb00bnrrp542

Issuer Name

APTAMER GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

nicholas slater

City of registered office (if applicable)

mill hill

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

25-Apr-2024

6. Date on which Issuer notified

25-Apr-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.980000

0.000000

3.980000

18583205

Position of previous notification (if applicable)

5.050000

0.000000

5.050000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BNRRP542

18583205

3.980000

Sub Total 8.A

18583205

3.980000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Below 4pct

12. Date of Completion

25-Apr-2024

13. Place Of Completion

london

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLPPUCCCUPCGCA
12
Date   Source Headline
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20248:45 amRNSHolding(s) in Company
23rd Apr 20242:03 pmRNSHolding(s) in Company - REPLACEMENT
22nd Apr 20244:37 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSTop Pharma Company evaluates Optimer for medicine
18th Apr 202410:06 amRNSTR-1: Notification of major holdings
18th Apr 20247:00 amRNSAptamer and Kairos Biotech partner for Optimer+
8th Apr 20247:00 amRNSPatent submission for Optimer® binders
28th Mar 20242:07 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSInterim Results
22nd Mar 20247:00 amRNSNotice of Interim Results & Investor Presentation
14th Mar 20247:00 amRNSInvestor Webinar
11th Mar 20247:00 amRNSAptamer Progresses Partnership with Unilever
29th Feb 20247:00 amRNSBlock Listing Interim Review
27th Feb 20247:00 amRNSR&D progress on new Optimer®+ platform
22nd Feb 20247:00 amRNSSecond Phase of Alzheimer's test with Neuro-Bio
5th Feb 20247:00 amRNSHalf Year Trading Update
4th Jan 20242:39 pmRNSHolding(s) in Company
15th Dec 20233:57 pmRNSResults of 2023 Annual General Meeting
15th Dec 20237:00 amRNSAGM Statement
14th Dec 20237:00 amRNSMaterial Agreement with Genetic Medicines Company
20th Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20237:00 amRNSFull year results for the 12mths ended 30 Jun 2023
8th Nov 202312:20 pmRNSNotice of Results and Investor Presentation
6th Nov 20237:00 amRNSTrading Update
24th Oct 202310:16 amRNSHolding(s) in Company
9th Oct 20239:40 amRNSGrant of Options and Related Party Transaction
19th Sep 20232:35 pmRNSPlacing and Subscription, PDMR Dealing and TVR
13th Sep 202312:58 pmRNSHolding(s) in Company
31st Aug 20237:00 amRNSHolding(s) in Company
24th Aug 20236:09 pmRNSHolding(s) in Company
24th Aug 20236:05 pmRNSHolding(s) in Company
21st Aug 20231:20 pmRNSHolding(s) in Company
21st Aug 20231:17 pmRNSHolding(s) in Company
17th Aug 202312:47 pmRNSResult of General Meeting
17th Aug 20237:00 amRNSContract wins
15th Aug 20235:43 pmRNSTR-1
15th Aug 20235:40 pmRNSTR-1
2nd Aug 20233:41 pmRNSHolding(s) in Company
2nd Aug 20233:38 pmRNSHolding(s) in Company
31st Jul 20239:04 amRNSForm 8.5 (EPT/RI)
31st Jul 20237:01 amRNSUpdate on Strategic Review and Formal Sale Process
31st Jul 20237:00 amRNSFundraise, Proposed Board Changes, RPT, GM Notice
28th Jul 20238:57 amRNSForm 8.5 (EPT/RI)
27th Jul 20239:36 amRNSForm 8.5 (EPT/RI) - Aptamer Group PLC
26th Jul 202310:57 amRNSResponse to Speculation, Strategic Review, Update
7th Jul 20237:00 amRNSContract Wins
4th Jul 20237:00 amRNSTrading Update
14th Jun 202312:16 pmRNSResponse to Share Price Movement
14th Jun 20237:00 amRNSAptamer & Neuro-Bio to develop Alzheimer’s test
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.